Volume 10, Issue 2 pp. 149-154

Insulin-related metabolism following hematopoietic stem cell transplantation in childhood

Ronit Elhasid

Corresponding Author

Ronit Elhasid

Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Dr Ronit Elhasid
Department of Pediatric Hemato-Oncology
Rambam Health Care Campus
PO Box 9602
Haifa 31096
Israel.
Tel: +972 4 854 2062;
Fax: +972 4 854 2007;
e-mail: [email protected]Search for more papers by this author
Yael A Leshem

Yael A Leshem

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Search for more papers by this author
Myriam Weyl Ben Arush

Myriam Weyl Ben Arush

Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Search for more papers by this author
Jacob M Rowe

Jacob M Rowe

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel

Search for more papers by this author
Naim Shehadeh

Naim Shehadeh

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Department of Pediatrics A, Rambam Health Care Campus, Haifa, Israel

Search for more papers by this author
First published: 23 February 2009
Citations: 5

Abstract

Objectives: To assess insulin-related metabolism following hematopoietic stem cell transplantation (HSCT) in childhood.

Study design: Thirty-four patients who underwent HSCT were compared with 21 patients with similar diseases who were not transplanted. Median follow-up was 3.6 yr after HSCT. Anthropometric parameters, fasting plasma glucose and insulin levels, hemoglobin A1c (HbA1c) and lipid profile were measured and compared.

Results: HbA1c was significantly higher (p = 0.001) in the study group. Two (5.8%) patients in the study group developed type 2 diabetes mellitus. Among thalassemic patients, significantly lower insulin resistance indices (p = 0.05) and fasting plasma insulin levels (p = 0.033) were found in the study group compared with the control group.

Conclusions: Attentive follow-up of insulin-related metabolism following HSCT in children is needed. The significance of the higher HbA1c values in the study group remains to be evaluated in a larger cohort of patients.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.